Ampicillin
Ampicillin for Injection, USP
Approved
Approval ID
8dbb4c71-8543-08f1-e053-2995a90af88d
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 21, 2022
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 013547657
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ampicillin sodium
PRODUCT DETAILS
NDC Product Code65219-014
Application NumberANDA062719
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 24, 2020
Generic Nameampicillin sodium
INGREDIENTS (1)
AMPICILLIN SODIUMActive
Quantity: 250 mg in 1 1
Code: JFN36L5S8K
Classification: ACTIM
ampicillin sodium
PRODUCT DETAILS
NDC Product Code65219-016
Application NumberANDA062719
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 24, 2020
Generic Nameampicillin sodium
INGREDIENTS (1)
AMPICILLIN SODIUMActive
Quantity: 500 mg in 1 1
Code: JFN36L5S8K
Classification: ACTIM
ampicillin sodium
PRODUCT DETAILS
NDC Product Code65219-020
Application NumberANDA062797
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 24, 2020
Generic Nameampicillin sodium
INGREDIENTS (1)
AMPICILLIN SODIUMActive
Quantity: 2 g in 1 1
Code: JFN36L5S8K
Classification: ACTIM
ampicillin sodium
PRODUCT DETAILS
NDC Product Code65219-018
Application NumberANDA062719
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 24, 2020
Generic Nameampicillin sodium
INGREDIENTS (1)
AMPICILLIN SODIUMActive
Quantity: 1 g in 1 1
Code: JFN36L5S8K
Classification: ACTIM